GlassScriptPhysician profile
Arun Prahash
NPI 1912984568
$1,331.66
in general payments reported to CMS, 2019-2025
17 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2021: $70.46 · 2022: $263 · 2023: $272 · 2024: $117 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $567.35 | 2019-2022 | |
| Pfizer INC. | $204.22 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $118.05 | 2019-2025 | |
| Shockwave Medical, INC | $69.35 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $64.62 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $59.45 | 2024-2025 | Camzyos, Eliquis |
| Philips North America LLC | $52.50 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.83 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $31.76 | 2025 | Verquvo |
| Cvrx, INC. | $22.41 | 2022 | |
| Kls-Martin L.P. | $19.67 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $18.64 | 2024 | Arcalyst |
| Amgen INC. | $18.62 | 2022 | |
| Teleflex LLC | $18.25 | 2025 | Turnpike |
| Sanofi-Aventis U.S. LLC | $16.85 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.09 | 2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Prahash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.